Evidence map›Paper›PMID 39817193›Full record

ArticleMolecular therapy. Nucleic acids2025

Multi-omic insights into molecular mechanism and therapeutic targets in spinocerebellar ataxia type 7.

Soo Hyun Ahn, Yoonhyuk Jang, Bum-Sup Jang, Jangsup Moon, Woo-Jin Lee, Dong-Kyu Park, Jung-Suk Yu, Hyoshin Son, Hyeyoon Kim, Dohyun Han and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular therapy. Nucleic acids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Soo Hyun AhnDepartment of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Yoonhyuk JangDepartment of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Bum-Sup JangDepartment of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Jangsup MoonDepartment of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Woo-Jin LeeDepartment of Neurology, Seoul National University Bundang Hospital, Seongnam-si 13620, Republic of Korea.
Dong-Kyu ParkLaboratory for Neurotherapeutics, Department of Neurology, Comprehensive Epilepsy Center, Center for Medical Innovation, Biomedical Research Institute, Seoul National University College of Medicine and Hospital, Seoul 03080, Republic of Korea.
Jung-Suk YuLaboratory for Neurotherapeutics, Department of Neurology, Comprehensive Epilepsy Center, Center for Medical Innovation, Biomedical Research Institute, Seoul National University College of Medicine and Hospital, Seoul 03080, Republic of Korea.
Hyoshin SonDepartment of Neurology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Republic of Korea.
Hyeyoon KimProteomics Core Facility, Biomedical Research Institute, Seoul National University Hospital, Seoul 03080, Republic of Korea.
Dohyun HanProteomics Core Facility, Biomedical Research Institute, Seoul National University Hospital, Seoul 03080, Republic of Korea.
Heeyoung SeokDepartment of Transdisciplinary Research and Collaboration, Genomics Core Facility, Biomedical Research Institute, Seoul National University Hospital, Seoul 03080, Republic of Korea.
Yongmoo KimDepartment of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Seo-Yi ShinDepartment of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Soon-Tae LeeDepartment of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Kyung-Il ParkDepartment of Neurology, Seoul National University Hospital Healthcare System Gangnam Center, Seoul 06236, Republic of Korea.
Keun-Hwa JungDepartment of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Daejong JeonAdvanced Neural Technologies, Seoul 03087, Republic of Korea.
Sang Kun LeeDepartment of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Kon ChuDepartment of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in molecular science have significantly enlightened our mechanistic understanding of spinocerebellar ataxia type 7. To further close remaining gaps, we performed a multi-omics analysis using SCA7

Indexed as

molecular targets in SCA7MT: Bioinformaticsmulti-omicsspinocerebellar ataxia 7

Identifiers

PMID39817193
PMCPMC11733039

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.